BTMD News and Press, Biote Corp.

2026-03-10 18:33:21 ET biote Corp. (BTMD) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in BTMD stock price following earnings has averaged ±9.00% , with a median of 8.32%. The sing...

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator advancing the healthspan of patients’ lives by providing hormone replacement therapy and healthy aging solutions, today announced the Company will provide fourth quarter and full year fin...

2025-11-06 10:15:12 ET B. Riley analyst issues NEUTRAL recommendation for BTMD on November 6, 2025 02:34PM ET. The previous analyst recommendation was Neutral. BTMD was trading at $2.87 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curr...

2025-11-05 19:41:56 ET More on BIOTE biote Corp. (BTMD) Q3 2025 Earnings Call Transcript Restructuring At Biote Will Drive Greater Growth And Profitability Seeking Alpha’s Quant Rating on BIOTE Historical earnings data for BIOTE Financial infor...

2025-11-05 19:41:15 ET biote Corp. (BTMD) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Bret Christensen - CEO & Director Robert Peterson - CFO and Chief Business Officer ... Read the full article on Seeking Alpha For further...

2025-11-05 17:02:29 ET More on BIOTE Restructuring At Biote Will Drive Greater Growth And Profitability Seeking Alpha’s Quant Rating on BIOTE  Historical earnings data for BIOTE  Financial information for BIOTE  Rea...

Continued progress against strategic priorities Repurchased approximately one million shares of Class A common stock Reiterates 2025 financial guidance Third Quarter 2025 Financial Highlights Revenue of $48.0 million Gross profit margin of 71.8% Net inc...

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide third quarter financial results on...

2025-09-10 12:23:39 ET Investment thesis When I previously analyzed biote Corp. ( BTMD ), “ biote Should Keep Delivering Strong Growth ” in November 2023, it had just returned to profitability and seemed poised for more advances.... Read the full arti...